Premium
Silexion Therapeutics Corporation (SLXN)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Latest preclinical studies reveal significant improvements in stability, efficacy, and KRAS targeting range for next-generation siRNA candidate SIL-204 Silexion Therapeutics Corp. (NASDAQ: SLXN...
New analysis from Silexion's Phase 2 trial of LODER shows a 56% objective response rate (ORR) and 67% resectability improvement in non-resectable pancreatic cancer Silexion Therapeutics Corp...
Report covers Silexion Therapeutics (NASDAQ: SLXN), a disruptive player in the precision oncology space, developing innovative RNAi therapies targeting KRAS-driven cancers, highlighting the...
RUNNEMEDE, N.J., Aug. 15 /PRNewswire-FirstCall/ -- Sielox, Inc. (OTC:SLXN) (BULLETIN BOARD: SLXN) , a developer, designer and distributor of security solution and industrial vision products...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0659 | -21.6776315789 | 0.304 | 0.3097 | 0.2281 | 740031 | 0.27055464 | CS |
| 4 | -0.2099 | -46.8526785714 | 0.448 | 0.46 | 0.2281 | 1662923 | 0.37678631 | CS |
| 12 | -4.3319 | -94.7899343545 | 4.57 | 4.65 | 0.2281 | 3258717 | 0.7936329 | CS |
| 26 | -4.3319 | -94.7899343545 | 4.57 | 4.65 | 0.2281 | 3258717 | 0.7936329 | CS |
| 52 | -4.3319 | -94.7899343545 | 4.57 | 4.65 | 0.2281 | 3258717 | 0.7936329 | CS |
| 156 | -4.3319 | -94.7899343545 | 4.57 | 4.65 | 0.2281 | 3258717 | 0.7936329 | CS |
| 260 | -4.3319 | -94.7899343545 | 4.57 | 4.65 | 0.2281 | 3258717 | 0.7936329 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
